Categories


Beasley Allen appointed to leadership role in Johnson & Johnson talc MDL

December 6, 2016 - Leigh O’Dell, Beasley Allen Principal, will serve as Co-Lead Counsel for multidistrict litigation (MDL) involving the Johnson & Johnson talc litigation consolidated in Trenton, N.J. Read More


Jury finds Johnson & Johnson, Imerys liable for $70 million in third ovarian cancer talc trial

October 27, 2016 - A third St. Louis jury has found Johnson & Johnson liable for ovarian cancer linked to talcum powder in its Johnson’s Baby Powder and Shower to Shower products. Talc supplier Imerys also... Read More


New Jersey Court ruling in talc hearing ignores internal documents

September 6, 2016 - Ruling to strike expert witnesses in New Jersey litigation ignores J&J admission that talc products carry ovarian cancer risk. Read More


Jere Beasley challenges J&J to release all talc documents, trial transcripts

August 25, 2016 - Announcing its appeal of two multimillion-dollar verdicts linking talc to ovarian cancer, Johnson & Johnson claims plaintiff lawyers created confusion about the link, while denying its own... Read More


Jere Beasley calls for Johnson & Johnson to end talc litigation

May 5, 2016 - Following another jury verdict finding Johnson & Johnson liable for ovarian cancer related to its talc products, Jere Beasley calls on the company to end talc litigation, pull talc products... Read More


Johnson & Johnson hit with second verdict linking talc products to ovarian cancer

May 2, 2016 - A Missouri state jury awarded Plaintiff Gloria Ristesund $55 million, finding J&J talcum powder products liable for her ovarian cancer. The verdict includes $5 million in actual damages and... Read More


Physician shares science of talcum powder link to ovarian cancer risk ahead of next scheduled trials

March 7, 2016 - Dr. Daniel Cramer has explained talcum powder link to ovarian cancer; discusses research as trial calendar for additional talc cases moves forward. Read More


Jere Beasley calls on Johnson & Johnson to release, publish internal documents on talc and ovarian cancer

February 26, 2016 - Johnson & Johnson documents showing link between regular talcum powder use for feminine hygiene and ovarian cancer risk were revealed at landmark trial resulting in $72 million verdict Read More


Johnson & Johnson hit with $72 million verdict in trial linking talcum powder to ovarian cancer

February 23, 2016 - A St. Louis jury found in favor of Plaintiff Jacqueline Fox, who alleged talcum powder use for feminine hygiene contributed to the development of her ovarian cancer. Read More


Lawsuits claim talcum powder products caused ovarian cancer

August 3, 2015 - Johnson & Johnson refuses to warn women that its talc containing products, like Johnson’s Baby Powder and Shower to Shower, can cause ovarian cancer despite four decades of studies... Read More


back to top